p51A (TAp63γ), a p53 homolog, accumulates in response to DNA damage for cell regulation

Oncogene

Volumn 19, Issue 27, 2000, Pages 3126-3130

  Katoh, Iyoko ^a   Aisaki, Ken Ichi ^a   Kurata, Shun Ichi ^a   Ikawa, Shuntaro ^b   Ikawa, Yoji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Bax; DNA damage; p21(waf1); p51; p53; p63

Indexed keywords

DACTINOMYCIN; PROTEIN BAX; PROTEIN P51; PROTEIN P53; UNCLASSIFIED DRUG; BAX PROTEIN, MOUSE; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; HEMOGLOBIN; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN BCL 2; PROTEIN SYNTHESIS INHIBITOR; TP73L PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; DNA TRANSFECTION; ERYTHROLEUKEMIA CELL; GENOTOXICITY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TRANSACTIVATION; ULTRAVIOLET RADIATION; ANIMAL; CELL CULTURE; DRUG EFFECT; ERYTHROLEUKEMIA; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; RADIATION EXPOSURE; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DACTINOMYCIN; DNA DAMAGE; DNA-BINDING PROTEINS; GENES, P53; GENES, TUMOR SUPPRESSOR; HEMOGLOBINS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; PHOSPHOPROTEINS; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 0034702133     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203644     Document Type: Article

References (34)

1. Agami R, Blandino G, Oren M and Shaul Y. (1999). Nature, 399, 809-813.
2. Aizawa S, Suda Y, Furuta Y, Yagi T, Takeda N, Watanabe N, Nagayoshi M and Ikawa Y. (1990). EMBO J., 9, 2107-2116.
3. Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y and Ziv Y. (1998). Science, 281, 1674-1677.
4. Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD. (1998). Science, 281, 1677-1679.
5. Celli J, Duijf P, Hamel BCJ, Bamshad M, Kramer B, Smits APT, Newbury-Ecob R, Hennekam RCM, Buggenhout GV, Haeringen AV, Woods CG, Essen AJV, Waal RD, Vriend G, Haver DA, Yang A, McKeon F, Brunner HG and Bokhoven HV. (1999). Cell, 99, 143-153.
6. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
7. Gong JG, Costanzo C, Yang H-Q, Melino G, Kaelin Jr WG, Levrero M and Wang JY. (1999). Nature, 399, 806-809.
8. Gu Y, Turk CW and Morgan DO. (1993). Nature, 366, 707-710.
9. Haapajärvi T, Pitkänen K, Tsubari M and Laiho M. (1997). Mol. Cell. Biol., 17, 3074-3080.
10. Hagiwara K, McMenamin MG, Miura K and Harris CC. (1999). Cancer Res., 59, 4165-4169.
11. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
12. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
13. Kato MV, Sato H, Nagayoshi M and Ikawa Y. (1997). Blood, 90, 1373-1378.
14. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
15. Kubbutat MHG, Jones SN and Vousden KH. (1997). Nature, 387, 299-308.
16. Levine AJ. (1997). Cell, 88, 323-331.
17. Lu X and Lane DP. (1993). Cell, 75, 765-778.
18. Lu X, Burbidge SA, Griffin S and Smith HM. (1996). Oncogene, 13, 413-418.
19. Martinez J, Georgoff I, Martinez J and Levine AJ. (1991). Genes Dev., 5, 151-159.
20. Michalovitz D, Halevy O and Oren M. (1990). Cell, 62, 671-680.
21. Mills AA, Zheng B, Wang X-J, Voge H, Roop DR and Bradley A. (1999). Nature, 398, 708-713.
22. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
23. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
24. Oltvai ZN, Milliman C and Korsmeyer SJ. (1993). Cell. 74, 609-619.
25. Osada M, Ohba M, Kawahara C, Ishioka C. Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M and Ikawa S. (1998). Nature Med., 4, 839-843.
26. Shieh S-Y, Ikeda M, Taya T and Prives C. (1997). Cell, 91, 325-334.
27. Shimada A, Kato S, Enjo K, Osada M, Ikawa Y, Obinata M, Ikawa S and Ishioka C. (1999). Cancer Res., 59, 2781-2786.
28. Sunahara M, Shishikura T, Takahashi M, Todo S, Yamamoto N, Kimura H, Kato S, Ishioka C, Ikawa S, Ikawa Y and Nakagawara A. (1999). Oncogene, 18, 3761-3765.
29. White E and Prives C. (1999). Nature, 399, 734-737.
30. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE and Lee PWK. (1998). Nature, 394, 700-704.
31. Xu X, Yamamura Y, Tsukada T, Yoshida MA, Senda H, Nagayoshi M, Ikeuchi T and Ikawa Y. (1995). Jpn. J. Cancer Res., 86, 284-291.
32. Yang A, Kaghad M, Wang Y, Gillet E, Flemming MD, Dötsch V, Andrews NC, Caput D and McKeon F. (1998). Mol. Cell., 2, 305-316.
33. Yang A, Schweizer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C and McKeon F. (1999). Nature, 398, 714-719.
34. Yuan Z-M, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R and Kufe D. (1999). Nature, 399, 814-817.